Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.66 - $2.79 $40,694 - $68,396
24,515 New
24,515 $42,000
Q1 2022

May 16, 2022

SELL
$2.97 - $5.2 $64,113 - $112,252
-21,587 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $66,317 - $99,143
13,290 Added 160.18%
21,587 $108,000
Q3 2021

Nov 15, 2021

BUY
$7.16 - $9.69 $59,406 - $80,397
8,297 New
8,297 $59,000
Q2 2021

Aug 16, 2021

SELL
$6.23 - $10.03 $20,041 - $32,266
-3,217 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $11,576 - $22,285
1,314 Added 69.05%
3,217 $30,000
Q4 2020

Feb 16, 2021

BUY
$8.5 - $12.85 $14,722 - $22,256
1,732 Added 1012.87%
1,903 $17,000
Q3 2020

Nov 16, 2020

BUY
$9.57 - $27.05 $1,636 - $4,625
171 New
171 $2,000
Q1 2020

May 15, 2020

SELL
$2.98 - $14.09 $33,435 - $158,089
-11,220 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.97 - $3.72 $22,103 - $41,738
11,220 New
11,220 $37,000
Q3 2019

Nov 14, 2019

SELL
$2.05 - $3.02 $8,595 - $12,662
-4,193 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.29 - $4.1 $9,601 - $17,191
4,193 New
4,193 $12,000
Q2 2018

Aug 14, 2018

SELL
$3.88 - $5.16 $981 - $1,305
-253 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.05 - $5.69 $1,024 - $1,439
253 New
253 $1,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $499M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.